PharmaEngine

Industry · 11 registered clinical trials — 3 currently recruiting.

Status	Trial	Phase	Started
Recruiting	A Study of PEP08 in Patients With MTAP-Del Advanced or Metastatic Solid Tumors Advanced Solid Tumor, Solid Tumors, MTAP-deleted Solid Tumors	Phase 1	2025-08-26
Recruiting	A Study of PEP07 (Checkpoint Kinase 1 Inhibitor) in Patients with Advanced or Metastatic Solid Tumors Advanced Solid Tumor, Metastatic Solid Tumor	Phase 1	2024-03-27
Recruiting	A Study of PEP07 (Checkpoint Kinase 1 Inhibitor) in Patients With Advanced Cancer Acute Myeloid Leukemia, Lymphoma, Mantle-Cell	Phase 1	2023-07-17
Completed	Nanoliposomal Irinotecan (Nal-IRI, ONIVYDE®) in Combination With TAS-102 (LONSURF®) in Refractory Solid Tumors Refractory Solid Tumors	Phase 1	2019-03-05
Terminated	A Study of PEP503 With Radiotherapy in Combination With Concurrent Chemotherapy for Patients With Head and Nec Head and Neck Squamous Cell Carcinoma	Phase 1 / Phase 2	2016-10-11
Terminated	A Study of PEP503(Radio-enhancer) With Radiotherapy and Chemotherapy for Patients With Rectal Cancer Rectal Cancer	Phase 1 / Phase 2	2015-06-01
Completed	Phase I and Pharmacokinetic Study of Biweekly PEP02 in mCRC Refractory to 1st-line Oxaliplatin Base Therapy Metastatic Colorectal Cancer	Phase 1	2009-06-01
Completed	Study of PEP02 as a Second Line Therapy for Metastatic Pancreatic Cancer Pancreatic Neoplasms	Phase 2	2009-01-01
Completed	Study of PEP02, Irinotecan or Docetaxel in Gastric or Gastroesophageal Junction Adenocarcinoma Stomach Neoplasms, Esophageal Neoplasms	Phase 2	2007-11-01
Completed	A Study of PEP02 in Combination With 5-fluorouracil (5-FU) and Leucovorin (LV) in Advanced Solid Tumors Solid Tumor	Phase 1	2006-01-01
Unknown	Two-Stage Study to Assess the Efficacy and Safety of 12 Weeks of Treatment With PEP03 in Patients With Chronic COPD	Phase 2	2004-09-01